Hemo Organic Limited
BSE: HEMORGANIC · Trading & Distributors · sector
Key numbers
Last 12 months to Sep 2026, Standalone. "Sector median" = middle value of 157 companies in Trading & Distributors (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹0 cr vs borrowings ₹4 cr (FY26): borrowings are higher by ₹4 cr.
- Net loss in 5 of the last 7 quarters.
- No dividend in the last 5 financial years.
- Price ₹21.85 on 2026-10-26: -10.5% from the 52-week high, +163.6% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 2 | 0 | 0 | 0 | 1 | 0 | 1 |
| EBITDA | 0 | -0 | -0 | -0 | -0 | -0 | 0 |
| OPM % | 6.2% | – | – | – | -32.3% | – | 0.7% |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | 0 | -0 | -0 | -0 | -1 | -0 | 0 |
| EPS (₹) | 1.08 | 0.25 | 0.09 | 0.45 | 1.46 | 0.21 | 0.01 |
| Revenue YoY | -61.4% | – | – | ||||
| Profit YoY | -237.8% | – | – |
Standalone figures where filed. Latest quarter Sep 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 2 | 1 | 2 |
| EBITDA | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -0 | -0 | -0 | 0 | -1 | -1 |
| EPS (₹) | -0.18 | -0.16 | -0.76 | 0.47 | 2.24 | 2.13 |
| Revenue growth | 0.0% | +100.0% | +11,950.0% | -61.4% | – | |
| Profit growth | – | – | – | -587.5% | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +352.9% | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | +39.0% (2y) | +173.1% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | -0 | 0 |
| Borrowings | 5 | 4 |
| Cash & equivalents | 0 | 0 |
| Total assets | 5 | 4 |
| Fixed assets | 0 | 0 |
| Capital work in progress | 0 | 0 |
| Investments | 0 | 0 |
| Receivables | 3 | 2 |
| Inventory | 1 | 1 |
| Payables | 0 | 0 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | -0 | -1 |
| Cash from investing | 0 | -1 |
| Cash from financing | 0 | 2 |
| Capex | 0 | 0 |
| Free cash flow | -0 | -1 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | -108.2% | -585.5% |
| ROCE % | 0.5% | -11.2% |
| Debtor days | 381 | 938 |
| Inventory days | 235 | 200 |
| Payable days | 0 | 0 |
| Cash conversion cycle (days) | 616 | 1,138 |
| Working capital days | 158 | 1,128 |
Peers in Trading & Distributors
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| REDINGTON | ₹28,671 cr | 16.9x | 2.8x | 18.0% | 18.4% | 1.9% | +14.5% | 1.85% |
| MMTC | ₹7,599 cr | 17.0x | 3.6x | 23.4% | 25.6% | 10,805.5% | -90.1% | – |
| MSTCLTD | ₹4,097 cr | 17.5x | 4.5x | 28.5% | 30.1% | 61.1% | -20.0% | 1.30% |
| CNL | ₹1,607 cr | 24.7x | 4.4x | 22.4% | 16.3% | 3.6% | +25.2% | 0.05% |
| BNAGROCHEM | ₹1,267 cr | 45.5x | 2.7x | 4.0% | 0.7% | -0.5% | – | – |
| YSL | ₹757 cr | 8.3x | 0.6x | 7.1% | 0.3% | 2.1% | +0.3% | 2.03% |
| SHIVAUM | ₹738 cr | 64.9x | 6.1x | 10.2% | 11.3% | 3.1% | – | – |
| STCINDIA | ₹594 cr | 0.9x | 1.0x | 228.5% | 108.2% | – | – | – |
| PERVASIVE | ₹587 cr | 0.1x | 6.5x | -0.2% | -0.1% | -0.9% | – | – |
| HEMORGANIC | ₹8 cr | 10.2x | 2.3x | -49.0% | -9.1% | -17.5% | +352.9% | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Services |
| Industry | Trading & Distributors |
| Sub-industry | Trading & Distributors |
| Symbol | HEMORGANIC |
| BSE code | 524590 |
| ISIN | INE422G01015 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.